DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Breaks Above Fifty Day Moving Average – Here’s What Happened

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $9.68 and traded as high as $9.96. DENTSPLY SIRONA shares last traded at $9.90, with a volume of 6,060,465 shares changing hands.

Wall Street Analyst Weigh In

XRAY has been the subject of several research reports. Leerink Partners decreased their price target on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a research note on Wednesday, October 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday. BMO Capital Markets dropped their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research note on Thursday, September 17th. Mizuho cut their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday, October 22nd. Finally, Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, October 9th. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.62.

DENTSPLY SIRONA Price Performance

The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The firm has a fifty day moving average price of $9.68 and a two-hundred day moving average price of $11.33. The stock has a market capitalization of $1.97 billion, a P/E ratio of -3.60, a P/E/G ratio of 1.21 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.17. The firm had revenue of $898.00 million during the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. DENTSPLY SIRONA’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in XRAY. CenterBook Partners LP raised its holdings in shares of DENTSPLY SIRONA by 46.8% during the third quarter. CenterBook Partners LP now owns 49,760 shares of the medical instruments supplier’s stock valued at $441,000 after purchasing an additional 15,858 shares during the last quarter. Villanova Investment Management Co lifted its position in DENTSPLY SIRONA by 13.4% during the third quarter. Villanova Investment Management Co now owns 191,770 shares of the medical instruments supplier’s stock valued at $1,699,000 after purchasing an additional 22,660 shares during the period. Commonwealth Equity Services LLC boosted its holdings in DENTSPLY SIRONA by 13.5% in the third quarter. Commonwealth Equity Services LLC now owns 1,800,822 shares of the medical instruments supplier’s stock worth $15,955,000 after purchasing an additional 213,988 shares during the last quarter. Bfsg LLC boosted its holdings in DENTSPLY SIRONA by 13.4% in the third quarter. Bfsg LLC now owns 22,230 shares of the medical instruments supplier’s stock worth $197,000 after purchasing an additional 2,620 shares during the last quarter. Finally, Chicago Partners Investment Group LLC grew its position in DENTSPLY SIRONA by 1,130.7% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 266,884 shares of the medical instruments supplier’s stock worth $2,517,000 after purchasing an additional 245,199 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.